Featured Research

from universities, journals, and other organizations

Experimental 'Coffee Cocktail' Tested As Way To Limit Stroke Damage

Date:
April 11, 2003
Source:
American Heart Association
Summary:
An experimental drug delivering the potency of two cups of strong coffee and a mixed drink has been shown to limit stroke-induced brain damage in animals. Now, this agent has been demonstrated to be safe in a small pilot study of ischemic stroke patients reported in Stroke: Journal of the American Heart Association.

DALLAS, April 11 – An experimental drug delivering the potency of two cups of strong coffee and a mixed drink has been shown to limit stroke-induced brain damage in animals. Now, this agent has been demonstrated to be safe in a small pilot study of ischemic stroke patients reported in today’s rapid access issue of Stroke: Journal of the American Heart Association.

This safety study is a crucial prelude to testing the effectiveness of the combination in patients. In previous studies in rats, the size of brain damage was reduced up to 80 percent when a combination of caffeine and ethanol, called caffeinol, was administered within three hours after an artery supplying blood to the brain was blocked (ischemic stroke).

Those studies “demonstrated that the combination of caffeine and ethanol may reduce the amount of damage after stroke. Neither caffeine or alcohol offered protection alone, but the combination was protective,” says senior author James C. Grotta, M.D., professor of neurology and director of the stroke program, University of Texas-Houston Medical School, Houston, Texas.

In this study, Grotta and colleagues sought to determine the safety and tolerability of caffeinol in humans.

Researchers administered the combination to 23 stroke patients (16 women, average age 71). The patients represented a diverse racial mix: nine white, nine black, four Hispanic and one Asian.

“Our goal was to see if we could safely achieve the same blood levels of caffeinol that we achieved in our animal studies,” he says. “We discovered that we could use even lower doses than we used in the animal studies and achieve the blood levels that were neuroprotective in animals.”

Moreover caffeinol, which is given by infusion, can be safely administered to patients who are also receiving clot-busting treatment with tissue plasminogen activator (tPA). Eight patients received both caffeinol and tPA. One patient with a very severe stroke who received caffeinol and tPA suffered an intracerebral hemorrhage (bleeding within the brain), but Grotta says an independent safety officer concluded it was not related to caffeinol.

The first set of four patients were given low-dose caffeinol (caffeine 6 milligrams per kilogram plus ethanol 0.2 grams per kilogram). That dose did not achieve the target blood level, so the dose was increased (8 mg/kg caffeine and 0.4 g/kg ethanol) in the next group of 19 patients. That achieved target blood levels, he says. However, Grotta cautioned that the ethanol level may need further adjustment because a patient with a history of heart disease developed reversible heart failure at that dose level. It is unclear how caffeinol works to protect the brain, but it is being studied.

A randomized, placebo-controlled trial is needed to determine the neuroprotective effect of this combination. In addition, Grotta plans a study that will combine caffeinol with thermo-cooling of stroke patients. Other studies have suggested that cooling the brain can limit stroke damage, and Grotta says that combining cooling and caffeinol may extend that protection.

Co-authors are Paisith Piriyawat, M.D.; W. Scott Burgin, M.D.; Lise A. Labiche, M.D.; and Jaroslaw A. Aronowski, Ph.D.

The research was funded in part by the National Institutes for Neurological Disorders and Stroke. Editor’s note: For more information on stroke, visit the American Stroke Association Web site: http://strokeassociation.org


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Experimental 'Coffee Cocktail' Tested As Way To Limit Stroke Damage." ScienceDaily. ScienceDaily, 11 April 2003. <www.sciencedaily.com/releases/2003/04/030411070831.htm>.
American Heart Association. (2003, April 11). Experimental 'Coffee Cocktail' Tested As Way To Limit Stroke Damage. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2003/04/030411070831.htm
American Heart Association. "Experimental 'Coffee Cocktail' Tested As Way To Limit Stroke Damage." ScienceDaily. www.sciencedaily.com/releases/2003/04/030411070831.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins